BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Free cash flow 2016–2023
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$20.5MFY2023 · since FY2016: -$6.0M → -$20.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$20.5M | -5.8% |
| FY2022 | -$19.3M | +27.2% |
| FY2021 | -$26.6M | +25.2% |
| FY2020 | -$35.6M | -203.5% |
| FY2019 | -$11.7M | +8.1% |
| FY2018 | -$12.8M | -401.5% |
| FY2017 | -$2.5M | +57.3% |
| FY2016 | -$6.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice